000 01406 a2200397 4500
005 20250517160054.0
264 0 _c20180409
008 201804s 0 0 eng d
022 _a1556-679X
024 7 _a10.1128/CVI.00060-17
_2doi
040 _aNLM
_beng
_cNLM
100 1 _avan Hooij, Anouk
245 0 0 _aLongitudinal IP-10 Serum Levels Are Associated with the Course of Disease Activity and Remission in Patients with Rheumatoid Arthritis.
_h[electronic resource]
260 _bClinical and vaccine immunology : CVI
_cAug 2017
500 _aPublication Type: Journal Article
650 0 4 _aAntirheumatic Agents
_xtherapeutic use
650 0 4 _aArthritis, Rheumatoid
_xblood
650 0 4 _aChemokine CXCL10
_xblood
650 0 4 _aDisease Progression
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aLongitudinal Studies
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aPoint-of-Care Systems
650 0 4 _aRetrospective Studies
650 0 4 _aSeverity of Illness Index
700 1 _aBoeters, Debbie M
700 1 _aTjon Kon Fat, Elisa M
700 1 _avan den Eeden, Susan J F
700 1 _aCorstjens, Paul L A M
700 1 _avan der Helm-van Mil, Annette H M
700 1 _aGeluk, Annemieke
773 0 _tClinical and vaccine immunology : CVI
_gvol. 24
_gno. 8
856 4 0 _uhttps://doi.org/10.1128/CVI.00060-17
_zAvailable from publisher's website
999 _c27256623
_d27256623